Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Georgian Med News ; (251): 21-6, 2016 Feb.
Artigo em Russo | MEDLINE | ID: mdl-27001781

RESUMO

Anterior ischemic optic neuropathy (AION) is one of the main reasons of vision disorders among middle-aged and elderly people. During the examination of patients with AION, we were interested by the fact of low efficiency of the standard treatment course. Moreover, over 60% of such patients underwent the development of AION on the other eye during 1 year after the beginning of the disease. The purpose of the given study is the development of efficient and original neuroprotection treatment scheme for AION, depending on the arterial pressure rate. We examined 58 patients (65 eyes) with AION, depending on the arterial pressure rate. The patients were divided into two clinical groups. For the first group of 38 patients (38 eyes), we used the original AION treatment scheme developed by us. The group was divided into 3 subgroups, depending on their arterial pressure rate: patients with normal ap., patients with hypertension of I-II stages and patients with hypotension. For the control group, the standard treatment scheme was used. The results received allow us to make a conclusion that the original treatment scheme, developed by us, is more efficient, and it can be recommended as a neuroprotection treatment scheme for AION among the patients with arterial hypertension of I-II stages.


Assuntos
Fármacos Neuroprotetores/uso terapêutico , Neuropatia Óptica Isquêmica/tratamento farmacológico , Anticoagulantes/uso terapêutico , Anti-Hipertensivos/uso terapêutico , Antioxidantes/uso terapêutico , Quimioterapia Combinada , Humanos , Peptídeos e Proteínas de Sinalização Intercelular , Pressão Intraocular , Neuropatia Óptica Isquêmica/fisiopatologia , Peptídeos/uso terapêutico , Receptores de N-Metil-D-Aspartato/antagonistas & inibidores , Acuidade Visual
2.
Vestn Oftalmol ; 108(1): 11-2, 1992.
Artigo em Russo | MEDLINE | ID: mdl-1585526

RESUMO

A new surgical method for the treatment of narrow-angle glaucoma is suggested, consisting in the following: in sinuso-trabeculectomy the bridge cut from the deep layers of the sclera via a diagonal incision is transformed into triangular flaps that are charged into the anterior chamber for the iris retraction. The new geometry of incisions improves the efficacy of iris retraction and makes the surgery less traumatic.


Assuntos
Glaucoma de Ângulo Fechado/cirurgia , Iris , Humanos , Trabeculectomia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...